10 employees
Symbiotix Biotherapies is a provider of a novel class of molecular therapeutics intended to develop molecules.
2009
$5M
from 1 investors over 1 rounds
Symbiotix Biotherapies, Inc. raised $5M on November 1, 2017
Investors: Kairos Ventures